215 related articles for article (PubMed ID: 816686)
1. [Evaluation of antibrucellosis vaccines using guinea pigs].
Le Garrec Y; Pilet C; Garrido-Calderon N
Dev Biol Stand; 1976; 31():301-7. PubMed ID: 816686
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of antibrucellic vaccines in mice].
Valette L; Stellmann C
Dev Biol Stand; 1976; 31():308-13. PubMed ID: 816687
[TBL] [Abstract][Full Text] [Related]
3. A recent trial comparing two 45/20 adjuvant Brucella vaccines.
McKeon FW
Dev Biol Stand; 1976; 31():343-50. PubMed ID: 816690
[TBL] [Abstract][Full Text] [Related]
4. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
Bolpe J; de Lapenta DF; García-Carrillo C
Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of the immunobiological properties of live brucellosis vaccines.
Salmakov KM; Fomin AM; Plotnikova EM; Safina GM; Galimova GM; Salmakova AV; Ivanov AV; Panin AN; Sklyarov OD; Shumilov KV; Klimanov AI
Vaccine; 2010 Oct; 28 Suppl 5():F35-40. PubMed ID: 20362201
[TBL] [Abstract][Full Text] [Related]
6. [Influence of the mouse genotype on the sensitivity to Brucella abortus 544].
Le Garrec Y; Garrido-Calderon N; Pilet C
Dev Biol Stand; 1976; 31():287-92. PubMed ID: 816685
[TBL] [Abstract][Full Text] [Related]
7. Control methods and thresholds of acceptability for antibrucella vaccines.
Bosseray N
Dev Biol Stand; 1992; 79():121-8. PubMed ID: 1286747
[TBL] [Abstract][Full Text] [Related]
8. Resistance of normal or immunized guinea pigs against a subcutaneous challenge of Brucella abortus.
Pardon P; Marly J
Ann Rech Vet; 1978; 9(3):419-25. PubMed ID: 107845
[TBL] [Abstract][Full Text] [Related]
9. Resistance of Brucella abortus infected mice to intravenous or intraperitoneal Brucella reinfection.
Pardon P; Marly J
Ann Immunol (Paris); 1976; 127(1):57-70. PubMed ID: 821385
[TBL] [Abstract][Full Text] [Related]
10. Brucella abortus vaccines: comparison of protection provided by immunopotentiated 45/20 bacterins and live strain 19 vaccine in guinea pigs.
Woodard LF; Toone NM; Jasman RL
Am J Vet Res; 1981 Nov; 42(11):1959-62. PubMed ID: 6802042
[TBL] [Abstract][Full Text] [Related]
11. The immunization of guinea-pigs and mice with a whole-culture extract of a smooth and a rough strain of Brucella abortus.
Keppie J; Witt K; Smith H
Br J Exp Pathol; 1972 Oct; 53(5):518-28. PubMed ID: 4628447
[TBL] [Abstract][Full Text] [Related]
12. Killed vaccine in adjuvant and protection of mice against an intraperitoneal challenge of Brucella: kinetic studies.
Pardon P; Marly J
Ann Rech Vet; 1976; 7(4):297-305. PubMed ID: 829301
[TBL] [Abstract][Full Text] [Related]
13. [Effect of simultaneous inoculation of B. abortus strain 19 and foot-and-mouth disease vaccines on immunity against brucellosis in the guinea pig].
García-Carrillo C
Rev Asoc Argent Microbiol; 1978; 10(1):1-7. PubMed ID: 210482
[No Abstract] [Full Text] [Related]
14. Vaccination against bovine brucellosis with a low dose of strain 19 administered by the conjunctival route. I.--Protection demonstrated in guinea pigs.
Plommet M; Plommet AM
Ann Rech Vet; 1975; 6(4):345-56. PubMed ID: 821381
[TBL] [Abstract][Full Text] [Related]
15. [Checking of anti-Brucella vaccines by counting the Brucella in the spleen of intraperitoneally innoculated, vaccinated or unvaccinated, mice].
Plommet M; Bosseray N
J Biol Stand; 1977; 5(4):261-74. PubMed ID: 411794
[No Abstract] [Full Text] [Related]
16. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
17. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
18. Post-exposure serological and bacteriological responses of water buffalo (Bubalus bubalis) to Brucella abortus biovar 1 following vaccination with Brucella abortus strain RB51.
Diptee MD; Asgarali Z; Campbell M; Fosgate G; Adesiyun AA
Rev Sci Tech; 2007 Dec; 26(3):669-78. PubMed ID: 18293615
[TBL] [Abstract][Full Text] [Related]
19. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
20. Immunization of guinea pigs with Salmonella delivered anti-Brucella formulation reduces organs bacterial load and mitigates histopathological consequences of Brucella abortus 544 challenge.
Lalsiamthara J; Lee JH
Vet Immunol Immunopathol; 2018 Jan; 195():40-45. PubMed ID: 29249316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
